BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6111090)

  • 1. Dualism in the alpha-adrenoceptor blocking action of dihydroergocristine.
    Lucchelli A; Zonta F; Grana E; Turba C; Pagella P
    Pharmacol Res Commun; 1981 Mar; 13(3):231-40. PubMed ID: 6111090
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens].
    Roquebert J; Demichel P; Gomond P; Malek A
    J Pharmacol; 1983; 14(2):151-9. PubMed ID: 6134866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the blocking effect of alpha-adrenoceptor antagonist drugs towards directly and indirectly acting agonists on the rat vas deferens.
    Lucchelli A; Santagostino-Barbone MG; D'Agostino G; Grana E
    Pharmacol Res Commun; 1983 Mar; 15(3):267-80. PubMed ID: 6134294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions and interactions of ergotamine and dihydroergocristine in rat aortic strips.
    Grana E; D'Agostino G; Zonta F; Lucchelli A
    Farmaco Sci; 1981 May; 36(5):334-43. PubMed ID: 6786918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification by desipramine of the effects of alpha-adrenoceptor antagonists on the contractile responses of the trisected rat vas deferens.
    Bradley L; Doggrell SA
    Gen Pharmacol; 1985; 16(5):475-82. PubMed ID: 2865190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of papaverine and verapamil on norepinephrine and calcium evoked contraction of vascular and non vascular smooth muscle.
    D'Agostino G; Zonta F; Dondi G; Grana E
    Pharmacol Res Commun; 1983 Nov; 15(10):937-49. PubMed ID: 6336540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.
    Doxey JC; Smith CF; Walker JM
    Br J Pharmacol; 1977 May; 60(1):91-6. PubMed ID: 18248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium on smooth muscles and on the adrenergic neuron blocking action of guanethidine.
    Chang CC; Lai FM; Chiueh CC
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):34-46. PubMed ID: 5102512
    [No Abstract]   [Full Text] [Related]  

  • 13. On the mechanism of papaverine action on the control of vascular smooth muscle contractile activity by extracellular calcium.
    Demesy F; Stoclet JC
    J Pharm Pharmacol; 1971 Sep; 23(9):712-3. PubMed ID: 4398255
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
    Bültmann R; Kurz AK; Starke K
    Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-adrenoceptor-blocking properties of some trypanocidal diamidines.
    Steinmann U; Estler CJ; Dann O
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):207-14. PubMed ID: 2895613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG; Vizi ES
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human vas deferens: correlation of response pattern to noradrenaline and histological structure.
    Amobi N; Smith IC
    Eur J Pharmacol; 1995 Jan; 273(1-2):25-34. PubMed ID: 7737316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine.
    Noamesi BK; Bamgbose SO
    Planta Med; 1980 May; 39(1):51-6. PubMed ID: 6105685
    [No Abstract]   [Full Text] [Related]  

  • 19. Excitatory and inhibitory effects of noradrenaline on the isolated guinea-pig vas deferens.
    Wadsworth RM
    Clin Exp Pharmacol Physiol; 1974; 1(2):135-45. PubMed ID: 4156501
    [No Abstract]   [Full Text] [Related]  

  • 20. Responsiveness of the guinea-pig vas deferens to phenylephrine and norepinephrine in vivo.
    Sannomiya P; De Moraes S
    Eur J Pharmacol; 1977 Nov; 46(1):59-62. PubMed ID: 923651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.